Onconetix, Inc. Common Stock ONCO
$3.58
-48.49%
at last close
Market Cap$4.09 million
P/E Ratio—
Div Yield—
Volume743.7K
52-Week Range
$3.34$2095.00
Key Stats
- Today's Range
- $3.34 – $7.10
- 50-Day Range
- $3.34 – $14.20
- 52-Week Range
- $3.34 – $2095.00
- Volume
- 744K shs
- Average Volume
- 457K shs
- Market Cap
- $4.09 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 98.26%
- Days to Cover
- 1.00
About Onconetix, Inc. Common Stock
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Related Stocks
Compare head-to-head: ONCO vs LLY·ONCO vs JNJ·ONCO vs ABBV·ONCO vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.